Methicillin-Resistant Staphylococcus aureus in Saarland, Germany: The Long-Term Care Facility Study


Background:
Multiresistant organisms pose a threat for patients and care recipients. Control interventions need to be tailored to region, the type of institution considered, and risk factors. The German state of Saarland is ideally suited to study colonisation epidemiology throughout its various health and care institutions. After conclusion of a large admission prevalence study in acute care hospitals, we now performed a methicillin-resistant Staphylococcus aureus (MRSA) point prevalence study in Saarland long term care facilities (LTCF), allowing for a direct comparison with respect of MRSA prevalence and associated risk factors between these two institutional types located within a confined region.

Methodology and Principal Findings:
Of all LTCF of the region, 65/136 participated in the study performed between 09/2013 and 07/2014. Overall, complete microbiological specimen and questionnaires of 2,858 of 4,275 (66.8%) LTCF residents were obtained. 136/2,858 (4.8%) screened residents revealed MRSA carrier status. Multivariate risk factor analysis yielded ulcer/deep soft tissue infection, urinary tract catheter, and MRSA history with multiple MRSA decolonisation cycles to be independently associated with MRSA carrier status.

Conclusion:
As already known from previous studies, colonisation with MRSA is common in LTCF residents even in an area with relatively low MRSA prevalence. This found prevalence can now be related to the acute care admission prevalence (2.2%) as well as to the admission prevalence in acute care geriatric departments (7.6%). The common clonal attribution (spatype) of MRSA isolates prevalent in the LTCF population as well as in the acute care admission population points towards a close relationship between both types of institutions. However, the ostensible absence of risk factors such as “previous hospitalisation” in conjunction with newly identified factors such as “multiple decolonisation cycles” refers to MRSA colonisation risks independent of contact with acute care facilities. Overall, this large LTCF point prevalence study allows data-based, region-tailored decisions on MRSA screening policies and provides a basis for additional preventative measures.


Autoři: Dorothea Nillius 1*;  Lutz Von Müller¤ 1;  Stefan Wagenpfeil 2;  Renate Klein 3;  Mathias Herrmann 1
Působiště autorů: Institute and State Laboratory of Medical Microbiology and Hygiene, Saarland University and Saarland University Medical Centre, Homburg, Germany 1;  Institute of Medical Biometry, Epidemiology, and Medical Informatics, Saarland University, Homburg, Germany 2;  Saarland Ministry of Social Affairs, Health, Women, and Family, Saarbrücken, Germany 3
Vyšlo v časopise: PLoS ONE 11(4)
Kategorie: Research article
prolekare.web.journal.doi_sk: 10.1371/journal.pone.0153030

© 2016 Nillius et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The electronic version of this article is the complete one and can be found online at: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0153030

Souhrn

Background:
Multiresistant organisms pose a threat for patients and care recipients. Control interventions need to be tailored to region, the type of institution considered, and risk factors. The German state of Saarland is ideally suited to study colonisation epidemiology throughout its various health and care institutions. After conclusion of a large admission prevalence study in acute care hospitals, we now performed a methicillin-resistant Staphylococcus aureus (MRSA) point prevalence study in Saarland long term care facilities (LTCF), allowing for a direct comparison with respect of MRSA prevalence and associated risk factors between these two institutional types located within a confined region.

Methodology and Principal Findings:
Of all LTCF of the region, 65/136 participated in the study performed between 09/2013 and 07/2014. Overall, complete microbiological specimen and questionnaires of 2,858 of 4,275 (66.8%) LTCF residents were obtained. 136/2,858 (4.8%) screened residents revealed MRSA carrier status. Multivariate risk factor analysis yielded ulcer/deep soft tissue infection, urinary tract catheter, and MRSA history with multiple MRSA decolonisation cycles to be independently associated with MRSA carrier status.

Conclusion:
As already known from previous studies, colonisation with MRSA is common in LTCF residents even in an area with relatively low MRSA prevalence. This found prevalence can now be related to the acute care admission prevalence (2.2%) as well as to the admission prevalence in acute care geriatric departments (7.6%). The common clonal attribution (spatype) of MRSA isolates prevalent in the LTCF population as well as in the acute care admission population points towards a close relationship between both types of institutions. However, the ostensible absence of risk factors such as “previous hospitalisation” in conjunction with newly identified factors such as “multiple decolonisation cycles” refers to MRSA colonisation risks independent of contact with acute care facilities. Overall, this large LTCF point prevalence study allows data-based, region-tailored decisions on MRSA screening policies and provides a basis for additional preventative measures.


Zdroje

1. Herrmann M, Petit C, Dawson A, Biechele J, Halfmann A, von Müller L, et al. Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening study. PloS One. 2013; 8(9):e73876. doi: 10.1371/journal.pone.0073876 PMID: 24040103

2. Mehraj J, Akmatov MK, Strompl J, Gatzemeier A, Layer F, Werner G, et al. Methicillin-sensitive and methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-hospitalized adult population in northern Germany. PLoS One. 2014; 9(9):e107937. doi: 10.1371/journal.pone.0107937 PMID: 25251407

3. Meyer E, Schröder C, Gastmeier P, Geffers C. The reduction of nosocomial MRSA infection in Germany: an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012. Dtsch Arztebl Int. 2014; 111(19):331–6. doi: 10.3238/arztebl.2014.0331 PMID: 24875457

4. Recommendations for prevention and control of methicillin-resistant staphylococcus aureus (MRSA) in medical and nursing facilities. Bundesgesundheitsblatt. 2014; 57(6):696–732.

5. Huang SS, Hinrichsen VL, Datta R, Spurchise L, Miroshnik I, Nelson K, et al. Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection. PLoS One. 2011; 6(9):e24340. doi: 10.1371/journal.pone.0024340 PMID: 21949707

6. Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis. 2008; 47(2):176–81. doi: 10.1086/589241 PMID: 18532892

7. Stamm AM, Long MN, Belcher B. Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control. 1993; 21(2):70–4. PMID:8498697

8. de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillinresistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2011; 55(4):1598–605. doi: 10.1128/AAC.01157-10 PMID: 21220533

9. Whitby M, McLaw ML, Berry G. Mortality rates associated with methicillin-resistant and -susceptible Staphylococcus aureus infections. Clin Infect Dis. 2003; 37(3):459–60. PMID: 12884174

10. Whitby M, McLaws M, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust. 2001; 175(5):264–67. PMID: 11587259

11. Cosgrove S, Sakoulas G, Perencevich E, Schwaber M, Karchmer A, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003; 36(1):53–9. doi: 10.1086/345476 PMID: 12491202

12. Ho KM, Robinson JO. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Anaesth Intensive Care. 2009; 37(3):457–63. PMID: 19499868

13. Pujol M, Pena C, Pallares R, Ariza J, Ayats J, Dominguez MA, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med. 1996; 100(5):509–16. PMID: 8644762

14. Yaw LK, Robinson JO, Ho KM. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis. 2014; 14(10):967–75. doi: 10.1016/S1473-3099(14)70876-X PMID: 25185461

15. Pfingsten-Würzburg S, Pieper DH, Bautsch W, Probst-Kepper M. Prevalence and molecular epidemiology of meticillin-resistant Staphylococcus aureus in nursing home residents in northern Germany. J Hosp Infect. 2011; 78(2):108–12. doi: 10.1016/j.jhin.2011.02.011 PMID: 21481969

16. Barr B, Wilcox MH, Brady A, Parnell P, Darby B, Tompkins D. Prevalence of methicillin-resistant Staphylococcus

aureus colonization among older residents of care homes in the United Kingdom. Infect Control Hosp Epidemiol. 2007; 28(7):853–59. doi: 10.1086/516795 PMID: 17564989

17. Manzur A, Gavalda L, Ruiz de Gopegui E, Mariscal D, Dominguez MA, Perez JL, et al. Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonization among residents in community long-term-care facilities in Spain. Clin Microbiol Infect. 2008; 14(9):867–72. doi: 10.1111/j.1469-0691.2008.02060.x PMID: 18844688

18. Bellini C, Petignat C, Masserey E, Bula C, Burnand B, Rousson V, et al. Universal screening and decolonization for control of MRSA in nursing homes: a cluster randomized controlled study. Infect Control Hosp Epidemiol. 2015; 36(4):401–8. doi: 10.1017/ice.2014.74 PMID: 25782894

19. Bradley S. Methicillin-resistant Staphylococcus aureus in nursing homes. Epidemiology, prevention and management. Drugs & Aging. 1997; 10(3):185–98.

20. Schaumburg F, Köck R, Mellmann A, Richter L, Hasenberg F, Kriegeskorte A, et al. Population dynamics among methicillin-resistant Staphylococcus aureus isolates in Germany during a 6-year period. J Clin Microbiol. 2012; 50(10):3186–92. doi: 10.1128/JCM.01174-12 PMID: 22814464

21. Eveillard M, Charru P, Rufat P, Hippeaux MC, Lancien E, Benselama F, et al. Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age Ageing. 2008; 37(3):294–99. doi: 10.1093/ageing/afn021 PMID: 18270245

22. Cassone M, Mody L. Colonization with Multi-Drug Resistant Organisms in Nursing Homes: Scope, Importance, and Management. Curr Geriatr Rep. 2015; 4(1):87–95. doi: 10.1007/s13670-015-0120-2 PMID: 25664233

23. Greub G, Prod'hom G. Automation in Clinical Bacteriology: What system to choose? Clin Microbiol Infect. 2011; 17(5):655–60. doi: 10.1111/j.1469-0691.2011.03513.x PMID: 21521409

24. Bourbeau P, Swartz B. First Evaluation of the WASP, a New Automated Microbiology Plating Instrument. J Clin Microbiol. 2009; 47(4):1101–6. doi: 10.1128/JCM.01963-08 PMID: 19158259

25. Warnke P, Harnack T, Ottl P, Kundt G, Podbielski A. Nasal screening for Staphylococcus aureus–daily routine with improvement potentials. PLoS One. 2014; 9(2):e89667. doi: 10.1371/journal.pone.0089667 PMID: 24586949

26. Warnke P, Frickmann H, Ottl P, Podbielski A. Nasal screening for MRSA: different swabs—different results! PLoS One. 2014; 9(10):e111627. doi: 10.1371/journal.pone.0111627 PMID: 25353631

27. Mellmann A, Friedrich A, Rosenkötter N, Rothgänger J, Karch H, Reintjes R, et al. Automated DNA sequence-based early warning system for the detection of Methicillin-resistant Staphylococcus aureus outbreaks. PLoS Med. 2006; 3(3):e33. doi: 10.1371/journal.pmed.0030033 PMID: 16396609

28. Becker K, Denis O, Roisin S, Mellmann A, Idelevich EA, Knaack D, et al. Detection of mecA- and mecC-positive methicillin-resistant Staphylococcus aureus (MRSA) isolates by the new Xpert MRSA Gen 3 PCR Assay. J Clin Microbiol. 2016; 54(1):180–4. doi: 10.1128/JCM.02081-15 PMID: 26491186

29. Statistical Office of the Saarland, Sachgebiet A 133 (Jugendhilfe P, Rechtspflege und Sozialleistungen). written communication (21.07.2014).

30. Anonymous. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus (MRSA)-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen. Bundesgesundheitsblatt. 2014; 57:696–732.

31. Anonymous. Infection prevention in the nursing home—Recommendations of the Commission for Hospital Hygiene and Infection Production of the Robert Koch Institute (RKI). Bundesgesundheitsblatt. 2005; 48:1061–80.

32. Anonymous. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen—Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am RKI. Bundesgesundheitsblatt. 1999; 42:954–8.

33. von Baum H, Schmidt C, Svoboda D, Bock-Hensley O, Wendt C. Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infect Control Hosp Epidemiol. 2002; 23(9):511–5. doi: 10.1086/502098 PMID: 12269448

34. Hogardt M, Proba P, Mischler D, Cuny C, Kempf VA, Heudorf U. Current prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-Main district, Germany, 2013. Euro Surveill. 2015; 20(26).

35. Heudorf U, Gustav C, Mischler D, Schulze J. Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt HALT plus MDRO project 2012. Bundesgesundheitsblatt. 2014; 57:414–22.

36. Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H, et al. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care—prevalence and risk factors. Int J Med Microbiol. 2013; 303(8):405-9. doi: 10.1016/j.ijmm.2013.05.002 PMID: 23770266

37. Pfingsten-Würzburg S, Pieper D, Bautsch W, Probst-Kepper M. Prevalence and molecular epidemiology of meticillin-resistant Staphylococcus aureus in nursing home residents in northern Germany. J Hosp Infect. 2011; 78(2):108–12. doi: 10.1016/j.jhin.2011.02.011 PMID: 21481969

38. Neuhaus B, Bocter N, Braulke C, Heuck C, Witte W. Studie zum Vorkommen von Methicillin-resistenten Staphylococcus aureus in Alten- und Altenpflegeheimen in Nordrhein-Westfalen. Bundesgesundheitsblatt. 2002; 45:894–904.

39. Reynolds C, Quan V, Kim D, Peterson E, Dunn J, Whealon M, et al. Methicillin-resistant Staphylococcus aureus (MRSA) carriage in 10 nursing homes in Orange County, California. Infect Control Hosp Epidemiol. 2011; 32(1):91–3. doi: 10.1086/657637 PMID: 21087124

40. O'Fallon E, Pop-Vicas A, D'Agata E. The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities. J Gerontol A Biol Sci Med Sci. 2009; 64(1):138–41. doi: 10.1093/gerona/gln020 PMID: 19164271

41. Trick W, Weinstein R, DeMarais P, Kuehnert M, TomaskaW, Nathan C, et al. Colonization of skilledcare facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc. 2001; 49(3):270–6. PMID: 11300237

42. Cheng V, Tai J, Wong Z, Chen J, Pan K, Hai Y, et al. Transmission of methicillin-resistant Staphylococcus aureus in the long term care facilities in Hong Kong. BMC Infect Dis. 2013; 13:205–14. doi: 10.1186/1471-2334-13-205 PMID: 23641974

43. Mossong J, Gelhausen E, Decruyenaere F, Devaux A, Perrin M, Even J, et al. Prevalence, risk factors and molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) colonization in residents of long-term care facilities in Luxembourg, 2010. Epidemiol Infect. 2013; 141(6):1199–206. doi: 10.1017/S0950268812001999 PMID: 22953727

44. Köck R, Brakensiek L, Mellmann A, Kipp F, Henderikx M, Harmsen D, et al. Cross-border comparison of the admission prevalence and clonal structure of meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2009; 71(4):320–6. doi: 10.1016/j.jhin.2008.12.001 PMID: 19201056

45. Greenland K, Rijnders M, Mulders M, Haenen A, Spalburg E, van de Kassteele J, et al. Low prevalence of methicillin-resistant Staphylococcus aureus in Dutch nursing homes. J Am Geriatr Soc. 2011; 59(4):768–9. doi: 10.1111/j.1532-5415.2011.03325.x PMID: 21492112

46. Andersson H, Lindholm C, Iversen A, Giske C, Ortqvist A, Kalin M, et al. Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis. 2012; 44(9):641–9. doi: 10.3109/00365548.2012.671956 PMID: 22680834

47. Grabe C, Buckard R, El-Ansari T, Käflein R. Flächendeckendes einmonatiges MRSA-Prävalenzscreening in Akut- und Rehakliniken in Siegen-Wittgenstein. Epidemiol Bulletin. 2010; 18:163–6.

48. Davis K, Stewart J, Crouch H, Florez C, Hospenthal D. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004; 39(6):776–82. doi: 10.1086/422997 PMID: 15472807

49. Hamed M, Nitsche-Schmitz D, Ruffing U, Steglich M, Dordel J, Nguyen D, et al. Whole genome sequence typing and microarray profiling of nasal and blood stream methicillin-resistant Staphylococcus aureus isolates: Clues to phylogeny and invasiveness. Infect Genet Evol. 2015; 36:475–82. doi: 10.1016/j.meegid.2015.08.020 PMID: 26297907

50. Hetem DJ, Bootsma MC, Troelstra A, Bonten MJ. Transmissibility of livestock-associated methicillinresistant Staphylococcus aureus. Emerg Infect Dis. 2013; 19(11):1797–802. doi: 10.3201/eid1911.121085 PMID: 24207050

51. Jans B, Schoevaerdts D, Huang T, Berhin C, Latour K, Bogaerts P, et al. Epidemiology of multidrugresistant microorganisms among nursing home residents in Belgium. PloS One. 2013; 8(5):e64908. doi: 10.1371/journal.pone.0064908 PMID: 23738011

52. Schoevaerdts D, Verroken A, Huang T, Frennet M, Berhin C, Jamart J, et al. Multidrug-resistant bacteria colonization amongst patients newly admitted to a geriatric unit: a prospective cohort study. J Infect. 2012; 65(2):109–18. doi: 10.1016/j.jinf.2012.02.004 PMID: 22343066

53. Stenehjem E, Rimland D. MRSA nasal colonization burden and risk of MRSA infection. Am J Infect Control. 2013; 41(5):405–10. doi: 10.1016/j.ajic.2012.07.017 PMID: 23261345

54. Robinson J, Phillips M, Christiansen K, Pearson J, Coombs G, Murray R. Knowing prior methicillinresistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality. Clin Microbiol Infect. 2014; 20(6):530–5. doi: 10.1111/1469-0691.12388 PMID: 24224545

55. Couderc C, Jolivet S, Thiebaut A, Ligier C, Remy L, Alvarez A, et al. Fluoroquinolone use is a risk factor for methicillin-resistant Staphylococcus aureus acquisition in long-term care facilities: a nested casecase- control study. Clin Infect Dis. 2014; 59(2):206–15. doi: 10.1093/cid/ciu236 PMID: 24729496

56. March A, Aschbacher R, Dhanji H, Livermore D, Böttcher A, Sleghel F, et al. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect. 2010; 16(7):934–44. doi: 10.1111/j.1469-0691.2009.03024.x PMID: 19686277

57. Rabinowitz R, Kufera J, Makley M. A hidden reservoir of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in patients newly admitted to an acute rehabilitation hospital. PM R. 2012; 4(1):18–22. doi: 10.1016/j.pmrj.2011.09.011 PMID: 22269450

58. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, et al. Universal screening for Methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008; 299(10):1149–57. doi: 10.1001/jama.299.10.1149 PMID: 18334690

59. Yoshida J, Kikuchi T, Matsubara N, Asano I, Ogami N. Association between ward-specific antimicrobial use density and methicillin-resistant Staphylococcu aureus surveillance: a 60-month study. Infect Drug Resist. 2013; 6:59–66. doi: 10.2147/IDR.S45843 PMID: 23901286

60. Morgan M. Methicillin-resistant Staphylococcus aureus and animals: Zoonosis or humanosis? J Antimicrob Chemother. 2008; 62(6):1181–7. doi: 10.1093/jac/dkn405 PMID: 18819971

61. Woltering R, Hoffmann G, Daniels-Haardt I, Gastmeier P, Chaberny IF. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in patients in long-term care in hospitals, rehabilitation centers and nursing homes of a rural district in Germany. Dtsch Med Wochenschr. 2008; 133(19):999–1003. doi: 10.1055/s-2008-1075683 PMID: 18446675


Článok vyšiel v časopise

PLOS One

Číslo 4

2016 Číslo 4

Najčítanejšie v tomto čísle

Tejto téme sa ďalej venujú…


Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

nový kurz
Autori: MUDr. Petr Výborný, CSc., FEBO

Autori: MUDr. Jiří Horažďovský, Ph.D

Zánětlivá bolest zad a axiální spondylartritida – Diagnostika a referenční strategie
Autori: MUDr. Monika Gregová, Ph.D., MUDr. Kristýna Bubová

Krvácení v důsledku portální hypertenze při jaterní cirhóze – od pohledu záchranné služby až po závěrečný hepato-gastroenterologický pohled
Autori: PhDr. Petr Jaššo, MBA, MUDr. Hynek Fiala, Ph.D., prof. MUDr. Radan Brůha, CSc., MUDr. Tomáš Fejfar, Ph.D., MUDr. David Astapenko, Ph.D., prof. MUDr. Vladimír Černý, Ph.D.

Rozšíření možností lokální terapie atopické dermatitidy v ordinaci praktického lékaře či alergologa
Autori: MUDr. Nina Benáková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa